Gliomatosis cerebri classification: Difference between revisions
| Line 24: | Line 24: | ||
*More common | *More common | ||
*Median age at diagnosis is 56 years | *Median age at diagnosis is 56 years | ||
*Mean survival time was longer (24 months) | *Mean survival time was longer than type 2 (24 months) | ||
*Predominantly low-grade | *Predominantly low-grade | ||
|- | |- | ||
| Line 34: | Line 34: | ||
*Less common | *Less common | ||
*Median age at diagnosis is 44 years | *Median age at diagnosis is 44 years | ||
*Mean survival time was shorter (21 months) | *Mean survival time was shorter than type 1 (21 months) | ||
*Predominantly high-grade | *Predominantly high-grade | ||
*''IDH1'' mutation is more common | *''IDH1'' mutation is more common | ||
Revision as of 19:54, 7 October 2015
|
Gliomatosis cerebri Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gliomatosis cerebri classification On the Web |
|
American Roentgen Ray Society Images of Gliomatosis cerebri classification |
|
Risk calculators and risk factors for Gliomatosis cerebri classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Gliomatosis cerebri may be classified into several subtypes based on the origin (primary and secondary) and the type of tumor cell (astrocytic, oligodendroglial, and mixed).[1][2][3][4]
Classification
1. Based on the origin
Gliomatosis cerebri may be classified based on the origin into two subtypes:[1][2][3]
| Type of gliomatosis cerebri | Characteristic features |
|---|---|
|
Type 1 (Primary) |
|
|
Type 2 (Secondary) |
|
2. Based on the type of tumor cell
Gliomatosis cerebri may be classified based on the predominant tumor cell type into three subtypes:[4]
- Astrocytic
- Oligodendroglial
- Mixed
References
- ↑ 1.0 1.1 Classification of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri
- ↑ 2.0 2.1 Brandão RA, de Carvalho GT, de Azeredo Coutinho CA, Christo PP, Santiago CF, Santos Mdo C; et al. (2011). "Gliomatosis cerebri: diagnostic considerations in three cases". Neurol India. 59 (1): 122–5. doi:10.4103/0028-3886.76892. PMID 21339680.
- ↑ 3.0 3.1 Park S, Suh YL, Nam DH, Kim ST (2009). "Gliomatosis cerebri: clinicopathologic study of 33 cases and comparison of mass forming and diffuse types". Clin Neuropathol. 28 (2): 73–82. PMID 19353837.
- ↑ 4.0 4.1 Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J; et al. (2004). "Initial chemotherapy in gliomatosis cerebri". Neurology. 63 (2): 270–5. PMID 15277619.